SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Einhorn TA 1998 The cell and molecular biology of fracture healing. Clin Orthop Suppl 355: S7S21.
  • 2
    De Biase P, Capanna R 2005 Clinical applications of BMPs. Injury 36(Suppl 3): S43S46.
  • 3
    Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH 2002 Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 96569661.
  • 4
    Hausman MR, Schaffler MB, Majeska RJ 2001 Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 29: 560564.
  • 5
    Alford AI, Hankenson KD 2006 Matricellular proteins: Extracellular modulators of bone development, remodeling, and regeneration. Bone 38: 749757.
  • 6
    Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA 1996 Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317: 5964.
  • 7
    Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW 1993 Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22: 147159.
  • 8
    Boskey AL, Spevak L, Paschalis E, Doty SB, McKee MD 2002 Osteopontin deficiency increases mineral content and mineral crystallinity in mouse bone. Calcif Tissue Int 71: 145154.
  • 9
    Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, Rittling SR, Denhardt DT, Hruska KA 2003 Osteopontin Deficiency Produces Osteoclast Dysfunction Due to Reduced CD44 Surface Expression. Mol Biol Cell 14: 173189.
  • 10
    Suzuki K, Zhu B, Rittling SR, Denhardt DT, Goldberg HA, McCulloch CA, Sodek J 2002 Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J Bone Miner Res 17: 14861497.
  • 11
    Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT 1998 Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13: 11011111.
  • 12
    Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M 2001 Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193: 399404.
  • 13
    Yoshitake H, Rittling SR, Denhardt DT, Noda M 1999 Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96: 81568160.
  • 14
    Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, Hruska KA, Higashio K, Enomoto S, Nifuji A, Rittling SR, Noda M 2001 Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem 276: 1306513071.
  • 15
    Koyama Y, Rittling SR, Tsuji K, Hino K, Salincarnboriboon R, Yano T, Taketani Y, Nifuji A, Denhardt DT, Noda M 2006 Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts. Endocrinology 147: 30403049.
  • 16
    Myers DL, Harmon KJ, Lindner V, Liaw L 2003 Alterations of arterial physiology in osteopontin-null mice. Arterioscler Thromb Vasc Biol 23: 10211028.
  • 17
    O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM 1994 Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 14: 16481656.
  • 18
    Bayless KJ, Meininger GA, Scholtz JM, Davis GE 1998 Osteopontin is a ligand for the alpha4beta1 integrin. J Cell Sci 111: 11651174.
  • 19
    Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M 1996 Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 149: 293305.
  • 20
    Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM 1994 Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 74: 214224.
  • 21
    Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M 1998 Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152: 353358.
  • 22
    Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM 1998 NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141: 10831093.
  • 23
    Yue TL, McKenna PJ, Ohlstein EH, Farach-Carson MC, Butler WT, Johanson K, McDevitt P, Feuerstein GZ, Stadel JM 1994 Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. Exp Cell Res 214: 459464.
  • 24
    Takagi H, Suzuma K, Otani A, Oh H, Koyama S, Ohashi H, Watanabe D, Ojima T, Suganami E, Honda Y 2002 Role of vitronectin receptor-type integrins and osteopontin in ischemia induced retinal neovascularization. Jpn J Ophthalmol 46: 270278.
  • 25
    Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, Denhardt DT, Noda M 2001 Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142: 13251332.
  • 26
    Yamazaki M, Nakajima F, Ogasawara A, Moriya H, Majeska RJ, Einhorn TA 1999 Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J Bone Joint Surg Br 81: 508515.
  • 27
    Hirakawa K, Hirota S, Ikeda T, Yamaguchi A, Takemura T, Nagoshi J, Yoshiki S, Suda T, Kitamura Y, Nomura S 1994 Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization. J Bone Miner Res 9: 15511557.
  • 28
    Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL 1998 Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101: 14681478.
  • 29
    Bonnarens F, Einhorn TA 1984 Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2: 97101.
  • 30
    Duvall CL, Robert Taylor W, Weiss D, Guldberg RE 2004 Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury. Am J Physiol Heart Circ Physiol 287: H302H310.
  • 31
    Junqueira LC, Bignolas G, Brentani RR 1979 Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447455.
  • 32
    Dayan D, Hiss Y, Hirshberg A, Bubis JJ, Wolman M 1989 Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers? Histochemistry 93: 2729.
  • 33
    Woessner JF Jr 1961 The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93: 440447.
  • 34
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 35973602.
  • 35
    Jepsen KJ, Pennington DE, Lee YL, Warman M, Nadeau J 2001 Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J Bone Miner Res 16: 18541862.
  • 36
    Helisch A, Wagner S, Khan N, Drinane M, Wolfram S, Heil M, Ziegelhoeffer T, Brandt U, Pearlman JD, Swartz HM, Schaper W 2006 Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol 26: 520526.
  • 37
    Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, Shu P, Moore KJ, Breslow JL, Smith JD 1999 Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19: 19601968.
  • 38
    Li CY, Schaffler MB, Wolde-Semait HT, Hernandez CJ, Jepsen KJ 2005 Genetic background influences cortical bone response to ovariectomy. J Bone Miner Res 20: 21502158.
  • 39
    Amblard D, Lafage-Proust MH, Laib A, Thomas T, Ruegsegger P, Alexandre C, Vico L 2003 Tail suspension induces bone loss in skeletally mature mice in the C57BL/6J strain but not in the C3H/HeJ strain. J Bone Miner Res 18: 561569.
  • 40
    Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Maenpaa PH 1999 Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J Biol Chem 274: 17291735.
  • 41
    Fantner GE, Hassenkam T, Kindt JH, Weaver JC, Birkedal H, Pechenik L, Cutroni JA, Cidade GA, Stucky GD, Morse DE, Hansma PK 2005 Sacrificial bonds and hidden length dissipate energy as mineralized fibrils separate during bone fracture. Nat Mater 4: 612616.
  • 42
    Hansma PK, Fantner GE, Kindt JH, Thurner PJ, Schitter G, Turner PJ, Udwin SF, Finch MM 2005 Sacrificial bonds in the interfibrillar matrix of bone. J Musculoskelet Neuron Interact 5: 313315.